Related Experiment Video
Updated: May 2, 2026
12:15
Generation of Monoclonal Antibodies Against Natural Products
Published on: April 6, 2019
10.8K
Baicalin: an active natural product with potential medicinal values
Yong-Qiang Wen1, Ya-Zhou Wang1, Chen-Xu Zhao1
1College of Veterinary Medicine, Northwest A&F University, Yangling 712100, China.
Journal of Asian Natural Products Research
|April 3, 2025
Summary
Baicalin, a plant flavonoid, shows promise for treating various conditions due to its anti-inflammatory and neuroprotective effects. Further research is needed to overcome its poor solubility for wider therapeutic applications.
Area of Science:
- Pharmacology
- Natural Products Chemistry
- Medicinal Chemistry
Background:
- Baicalin is a flavonoid from *Scutellaria baicalensis* Georgi (SBG).
- It exhibits diverse pharmacological activities including anti-inflammatory, antiviral, antibacterial, hepatoprotective, lipid-lowering, and neuroprotective effects.
- Limited aqueous solubility of baicalin hinders its bioavailability and therapeutic efficacy.
Purpose of the Study:
- To review the pharmacological properties of baicalin.
- To discuss its pharmacokinetics, cytotoxicity, and potential drug interactions.
- To explore the therapeutic potential of baicalin, particularly for cardiovascular diseases, obesity, and liver-lipid disorders.
Main Methods:
- Literature review of existing studies on baicalin.
- Analysis of pharmacological data, including efficacy and safety profiles.
- Evaluation of pharmacokinetic and drug interaction studies.
Main Results:
- Baicalin demonstrates significant anti-inflammatory, antiviral, antibacterial, hepatoprotective, lipid-lowering, and neuroprotective properties.
- Key challenges include baicalin's poor solubility and absorption, impacting its in vivo effectiveness.
- Potential applications span medicine, functional foods, and cosmetics.
Conclusions:
- Baicalin possesses a broad spectrum of pharmacological activities with therapeutic potential.
- Addressing solubility and absorption limitations is crucial for its clinical and commercial development.
- Further investigation into baicalin's applications in various health-related fields is warranted.
More Related Videos
09:16Author Spotlight: Optimization of Processing Technology for Tiebangchui with Zanba Based on CRITIC Combined with Box-Behnken Response Surface Method
Published on: May 12, 2023
1.0K
07:50Author Spotlight: Integrating 2D-HPLC-MS and Molecular Networking in Natural Medicine Analysis
Published on: December 8, 2023
402
Related Concept Videos
01:16Drug Biotransformation: Overview
3.7K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.7K
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
1.7K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.7K
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
332
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
332
01:28Drug Products: Biologics, Biosimilars and Interchangeables
369
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
369
01:20Drug Product Performance: In Vitro–In Vivo Correlation
431
In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while...
431
01:24iChip
105
The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...
105